Oct 11, 2022 11:00:00 AM       by Baoqi He

Cellular Senescence: Aging Gracefully

Reaching the golden years doesn’t always feel so golden. As we age, disease, injury, and other stress factors from the environment will damage our bodies' cells. Most cells may be able to repair that damage, while our immune system usually clears those damaged cells through a process called apoptosis.[1] However, if cellular repair and clearance is not effective, the residual damaged cells will further weaken the immune system and deteriorate other biological processes. Is there a possibility that we can avoid this cellular damage and improve the health of older people? A cellular state known as senescence might hold the key to this question.[1, 2] During senescence, the damaged cells irreversibly stop dividing and resist being removed. [3] Researchers have shown that determining senescence biomarkers could lead to new therapies for the inflammatory disease caused by senescence in older people.[4]


Aug 15, 2022 11:37:47 AM       by Kin Leung

CUT&Tag: An Alternative to Chromatin Immunoprecipitation

The arguably most fun thing about science is when your supervisor tells you to just do Experiment X to test hypothesis, but then they kind of forget to tell you how complicated the techniques are to perform that experiment, not to mention all the optimization you would need to do. I personally have never done a chromatin immunoprecipitation (ChIP), and since I wasn’t in genomics, the most sequencing I ever did was setting up quick reactions for the core facility to tell me that my gene constructs were correctly built. ChIP does sound rather simple when explained in class, but when you read up on the protocols,1 there are some limitations to what ChIP can do, especially given the large amount of starting material you need for the typical experiment. Luckily, in recent years, scientists have started to use an alternative technique called Cleavage Under Targets and Tagmentation, or CUT&Tag, which ABclonal is pleased to support through our antibody reagents.


Jul 27, 2022 11:29:58 AM       by Gavin Zhang

The ABclonal Advantage: Working With an Original Manufacturer

When you consider which of the dozens of biological reagents companies to work with, how can you determine which one is the right fit? There is, of course, a business aspect to making and distributing quality antibody reagents. The source of the antibodies that you rely on for your research will matter in terms of supply consistency, lead time, cost, and the associated services to support your product. 


Jul 18, 2022 11:59:58 AM       by Kin Leung

What to Think About Zinc: An Essential Element for Healthy Living

Perhaps we only think of zinc as the extra element in our coins to keep manufacturing costs down, or as that random clip from the Simpsons about a world without zinc. Aside from thinking it is a wacky sounding word (I did look up the etymology and it is rather appropriate!), we just don’t consider zinc as being all that important. Once the pandemic hit, though, I noted that Costco was marketing their zinc supplements a lot more, and after doing some extra research, I bought some to add to my diet.


Jul 13, 2022 12:00:00 PM       by Kin Leung

ABclonal in Action: 10 Scientific Studies Using ABclonal Antibodies

Open collaboration is important for sustainable science, and every new study or publication, no matter the journal or institution, contributes to a greater understanding of biology, for better or for worse. Dozens of prior discoveries funnel into every new breakthrough, so we need to appreciate the years of painstaking labor and thought that go into every new morsel of knowledge. It is very fulfilling when ABclonal products are part of the fuel that drives these studies in diverse fields of biology. With our ABclonal in Action series, we hope to highlight our products as well as the new insights from our customers all over the globe that will become stepping stones for the next generation of cutting-edge bioscience.

 


Jun 10, 2022 12:00:00 PM       by Kin Leung

ABclonal in Action: Autophagy as a Therapeutic Target

 

Every now and then when I get hungry, I joke that my stomach is about to digest itself. For the longest time, human science was unaware that our cells could literally eat itself (or more precisely, parts of itself) as well! First described in the 1960s by Christian de Duve (who won the Nobel Prize for discovering the lysosome), the term autophagy derives from Greek words combined to mean “self-eating” and describes a process by which the cell degrades large components and organelles in a distinct mechanism. 1-3 The phenomenon was not studied extensively until the 1990s, when Yoshinori Ohsumi performed a series of groundbreaking experiments to determine the underlying mechanisms of autophagy, an achievement for which he was awarded the 2016 Nobel Prize in Physiology or Medicine. Ohsumi’s work has led to an explosion of research that has precipitated a greater understanding of the role played by cellular digestion, degradation, and recycling pathways in human health and disease.